首页 > 最新文献

Journal of Hepato‐Biliary‐Pancreatic Sciences最新文献

英文 中文
Global Trends in Perioperative Imaging Workups and Records for Hepatobiliary and Pancreatic Surgery: Reports From 103 Facilities Worldwide. 肝胆胰手术围手术期影像学检查和记录的全球趋势:来自全球103家机构的报告。
IF 2.8 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-10-14 DOI: 10.1002/jhbp.70017
Yoshihiro Sakamoto, Goro Honda, Taizo Hibi, Tomoyuki Yoshida, Shohei Kudo, Nobuhiro Hasui, Hirokazu Momose, Ryota Matsuki, Masaharu Kogure, Mureo Kasahara

Background: Perioperative imaging workups and records, including preoperative schema-drawing, three-dimensional tomographic image simulation, intraoperative ultrasonography, fluorescence imaging in hepatectomy, and postoperative record with illustration, may be helpful to perform and educate safe and accurate hepato-biliary-pancreatic (HBP) surgery. The purpose of this study is to elucidate the global usage of image-analyzing methods in HBP surgery.

Methods: Twenty-four questions were sent to 182 HBP and transplantation surgeons in 177 academic institutions in 34 countries worldwide to examine the usage of perioperative image-analyzing methods, surgical volume, and introduction of minimally invasive (MI) approaches.

Results: Questionnaire responses were obtained from 107 surgeons at 103 institutions across 27 countries (response rate, 58.2%). Perioperative schema-drawing (97% vs. 41%), three-dimensional simulation (100% vs. 58%), and operation record with illustration (100% vs. 41%), were best utilized in Japan (p < 0.001). The number of hepatectomy, liver transplantation, pancreatectomy, introduction of MI approaches was significantly associated with a larger number of surgical staffs (≥ 12) in each institution, but not with the imaging workups and records.

Conclusion: Japan made optimal use of perioperative image-analyzing methods; however, they are not of global standard. Surgical volume and introduction of MI-HBP surgery were associated with the number of surgical staff.

背景:围手术期影像学检查和记录,包括术前方案绘制、三维断层图像模拟、术中超声检查、肝切除术中的荧光成像以及术后有插图的记录,可能有助于实施和指导安全、准确的肝胆胰(HBP)手术。本研究的目的是阐明图像分析方法在HBP手术中的整体应用。方法:向全球34个国家177个学术机构的182名HBP和移植外科医生发送24个问题,以检查围手术期图像分析方法的使用、手术量和微创(MI)入路的引入。结果:对27个国家103家机构的107名外科医生进行问卷调查(回复率为58.2%)。围手术期方案绘制(97%对41%)、三维模拟(100%对58%)和手术记录插图(100%对41%)在日本得到了最好的利用(p结论:日本对围手术期图像分析方法的利用是最佳的,但它们不是全球标准。手术量和MI-HBP手术的引入与手术人员的数量有关。
{"title":"Global Trends in Perioperative Imaging Workups and Records for Hepatobiliary and Pancreatic Surgery: Reports From 103 Facilities Worldwide.","authors":"Yoshihiro Sakamoto, Goro Honda, Taizo Hibi, Tomoyuki Yoshida, Shohei Kudo, Nobuhiro Hasui, Hirokazu Momose, Ryota Matsuki, Masaharu Kogure, Mureo Kasahara","doi":"10.1002/jhbp.70017","DOIUrl":"https://doi.org/10.1002/jhbp.70017","url":null,"abstract":"<p><strong>Background: </strong>Perioperative imaging workups and records, including preoperative schema-drawing, three-dimensional tomographic image simulation, intraoperative ultrasonography, fluorescence imaging in hepatectomy, and postoperative record with illustration, may be helpful to perform and educate safe and accurate hepato-biliary-pancreatic (HBP) surgery. The purpose of this study is to elucidate the global usage of image-analyzing methods in HBP surgery.</p><p><strong>Methods: </strong>Twenty-four questions were sent to 182 HBP and transplantation surgeons in 177 academic institutions in 34 countries worldwide to examine the usage of perioperative image-analyzing methods, surgical volume, and introduction of minimally invasive (MI) approaches.</p><p><strong>Results: </strong>Questionnaire responses were obtained from 107 surgeons at 103 institutions across 27 countries (response rate, 58.2%). Perioperative schema-drawing (97% vs. 41%), three-dimensional simulation (100% vs. 58%), and operation record with illustration (100% vs. 41%), were best utilized in Japan (p < 0.001). The number of hepatectomy, liver transplantation, pancreatectomy, introduction of MI approaches was significantly associated with a larger number of surgical staffs (≥ 12) in each institution, but not with the imaging workups and records.</p><p><strong>Conclusion: </strong>Japan made optimal use of perioperative image-analyzing methods; however, they are not of global standard. Surgical volume and introduction of MI-HBP surgery were associated with the number of surgical staff.</p>","PeriodicalId":16056,"journal":{"name":"Journal of Hepato‐Biliary‐Pancreatic Sciences","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145292426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Pilot Study on the Efficacy and Safety of Sedation With Remimazolam in Japanese Patients Undergoing Endoscopic Retrograde Cholangiopancreatography 日本患者行内窥镜逆行胆管造影时使用雷马唑仑镇静的有效性和安全性的初步研究。
IF 2.8 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-10-12 DOI: 10.1002/jhbp.70018
Shuhei Shintani, Takayoshi Mizuno, Jun Matsubayashi, Takuya Okamoto, Kosuke Hiroe, Atsushi Nishida, Hirotoshi Kitagawa, Osamu Inatomi, Takuji Iwashita

Objectives

Remimazolam is a novel, ultra-short-acting benzodiazepine. Remimazolam is characterized by rapid induction and recovery and low cardiopulmonary effects. The present study aimed to examine the safety and efficacy of a sedation method combining remimazolam and pentazocine during endoscopic retrograde cholangiopancreatography (ERCP) in a Japanese cohort.

Methods

The present investigation was a single-center, single-arm, Phase 2 study. The primary endpoint was successful endoscopic sedation. The initial dose was induced with remimazolam (0.1 mg/kg) and pentazocine (3.75 mg). Remimazolam (0.05 mg/kg) and the same dose of pentazocine as the initial dose were added as needed in response to body movements or signs of discomfort during the procedure.

Results

A total of 59 patients [median age (range): 75 years (48–87 years), 47 male (79.7%)] were enrolled. Successful endoscopic sedation was achieved in all patients. One patient (1.7%) experienced transient circulatory depression, with no instances of respiratory depression or need for flumazenil reversal. Post-procedure alertness was achieved within 5 and 10 min in 52 (88.1%) and 58 patients (98.3%), respectively.

Conclusion

Sedation with remimazolam and pentazocine in ERCP demonstrated high efficacy and a favorable safety profile in the Japanese population.

Trial Registration

This trial was registered in the Japan Registry of Clinical Trials (jRCTs051230088)

目的:雷马唑仑是一种新型超短效苯二氮卓类药物。雷马唑仑的特点是诱导和恢复快,对心肺的影响小。本研究旨在研究雷马唑仑和戊唑嗪联合镇静方法在内镜逆行胆管胰胆管造影(ERCP)中的安全性和有效性。方法:本研究为单中心、单组、2期研究。主要终点是成功的内镜镇静。初始剂量为雷马唑仑(0.1 mg/kg)和戊唑嗪(3.75 mg)。在手术过程中,根据身体运动或不适迹象的需要,加入雷马唑仑(0.05 mg/kg)和与初始剂量相同剂量的戊唑嗪。结果:共入组59例患者,中位年龄(范围):75岁(48 ~ 87岁),男性47例(79.7%)。所有患者均成功实现内窥镜镇静。1例患者(1.7%)出现短暂性循环抑制,无呼吸抑制或需要氟马西尼逆转。52例(88.1%)和58例(98.3%)患者分别在5分钟和10分钟内达到术后警觉。结论:在日本人群中,雷马唑仑和戊唑嗪在ERCP中显示出较高的镇静效果和良好的安全性。试验注册:该试验已在日本临床试验注册中心注册(jRCTs051230088)。
{"title":"A Pilot Study on the Efficacy and Safety of Sedation With Remimazolam in Japanese Patients Undergoing Endoscopic Retrograde Cholangiopancreatography","authors":"Shuhei Shintani,&nbsp;Takayoshi Mizuno,&nbsp;Jun Matsubayashi,&nbsp;Takuya Okamoto,&nbsp;Kosuke Hiroe,&nbsp;Atsushi Nishida,&nbsp;Hirotoshi Kitagawa,&nbsp;Osamu Inatomi,&nbsp;Takuji Iwashita","doi":"10.1002/jhbp.70018","DOIUrl":"10.1002/jhbp.70018","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>Remimazolam is a novel, ultra-short-acting benzodiazepine. Remimazolam is characterized by rapid induction and recovery and low cardiopulmonary effects. The present study aimed to examine the safety and efficacy of a sedation method combining remimazolam and pentazocine during endoscopic retrograde cholangiopancreatography (ERCP) in a Japanese cohort.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The present investigation was a single-center, single-arm, Phase 2 study. The primary endpoint was successful endoscopic sedation. The initial dose was induced with remimazolam (0.1 mg/kg) and pentazocine (3.75 mg). Remimazolam (0.05 mg/kg) and the same dose of pentazocine as the initial dose were added as needed in response to body movements or signs of discomfort during the procedure.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 59 patients [median age (range): 75 years (48–87 years), 47 male (79.7%)] were enrolled. Successful endoscopic sedation was achieved in all patients. One patient (1.7%) experienced transient circulatory depression, with no instances of respiratory depression or need for flumazenil reversal. Post-procedure alertness was achieved within 5 and 10 min in 52 (88.1%) and 58 patients (98.3%), respectively.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Sedation with remimazolam and pentazocine in ERCP demonstrated high efficacy and a favorable safety profile in the Japanese population.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Trial Registration</h3>\u0000 \u0000 <p>This trial was registered in the Japan Registry of Clinical Trials (jRCTs051230088)</p>\u0000 </section>\u0000 </div>","PeriodicalId":16056,"journal":{"name":"Journal of Hepato‐Biliary‐Pancreatic Sciences","volume":"32 12","pages":"938-944"},"PeriodicalIF":2.8,"publicationDate":"2025-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145280332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drill Crush Technique: A Novel Lithotripsy Method for Giant Bile Duct Stone Removal in a Patient With Surgically Altered Anatomy (With Video) 钻孔粉碎技术:一种新的碎石方法,用于切除手术改变解剖结构的胆管结石(附视频)。
IF 2.8 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-10-12 DOI: 10.1002/jhbp.70016
Takehiko Koga, Keisuke Matsumoto, Yusuke Ishida, Naoaki Tsuchiya, Takanori Kitaguchi, Makoto Fukuyama, Yi-Ling Ko, Fumihito Hirai

With accompanying video, Koga and colleagues describe the drill crush technique, a novel endoscopic method for removing large impacted bile duct stones in patients with surgically altered anatomy. Using a screw-type drill dilator, this stepwise approach enables safe and effective lithotripsy and offers a minimally invasive alternative when conventional methods fail.

在视频中,Koga和他的同事描述了钻压技术,这是一种新的内镜方法,用于切除手术改变解剖结构的患者的大块阻生胆管结石。使用螺旋型钻孔扩张器,这种分步方法可以安全有效地进行碎石,并在常规方法失败时提供微创替代方案。
{"title":"Drill Crush Technique: A Novel Lithotripsy Method for Giant Bile Duct Stone Removal in a Patient With Surgically Altered Anatomy (With Video)","authors":"Takehiko Koga,&nbsp;Keisuke Matsumoto,&nbsp;Yusuke Ishida,&nbsp;Naoaki Tsuchiya,&nbsp;Takanori Kitaguchi,&nbsp;Makoto Fukuyama,&nbsp;Yi-Ling Ko,&nbsp;Fumihito Hirai","doi":"10.1002/jhbp.70016","DOIUrl":"10.1002/jhbp.70016","url":null,"abstract":"<p>With accompanying video, Koga and colleagues describe the drill crush technique, a novel endoscopic method for removing large impacted bile duct stones in patients with surgically altered anatomy. Using a screw-type drill dilator, this stepwise approach enables safe and effective lithotripsy and offers a minimally invasive alternative when conventional methods fail.\u0000 <figure>\u0000 <div><picture>\u0000 <source></source></picture><p></p>\u0000 </div>\u0000 </figure></p>","PeriodicalId":16056,"journal":{"name":"Journal of Hepato‐Biliary‐Pancreatic Sciences","volume":"32 12","pages":"e70-e72"},"PeriodicalIF":2.8,"publicationDate":"2025-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145280420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidence and Risk Factors of Symptomatic Venous Gas Embolism During Laparoscopic Liver Resection 腹腔镜肝切除术中症状性静脉气体栓塞的发生率及危险因素。
IF 2.8 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-10-09 DOI: 10.1002/jhbp.70013
Walid Hadji, Nassiba Beghdadi, Chady Salloum, Claire Goumard, Safi Dokmak, Chetana Lim, Stéphanie Roullet, Rania Bounab, Djillali Annane, Mickaël Lesurtel, Olivier Scatton, Daniel Cherqui, Marc Antoine Allard

Background

Risk factors of symptomatic venous gas embolism (GE) during laparoscopic liver resection (LLR) are poorly known. The objective of this study was to report the incidence, risk factors, and morbidity of symptomatic GE during LLR.

Methods

All consecutive patients who underwent LLR in 3 French centers over 3 years were retrospectively studied. All intraoperative events, with a focus on symptomatic venous GE, were collected and reviewed.

Results

Among the 518 LLR (507 patients) studied, 26 (5%) cases of symptomatic GE occurred. There was no GE-related death nor neurological sequelae after GE. The group of patients with GE and without GE was similar in terms of baseline characteristics, type of resection, and pneumoperitoneum pressure (≤ 12 mmHg in 93% of LLR) or intraoperative bleeding. Overall morbidity and length of stay were longer after GE. The probability of GE was higher under the Airseal insufflation system at 12 mmHg (7.1% with Airseal versus 0.59% with conventional systems, odds ratio 12.73, 95% confidence interval [2.66–228.4], p = 0.013).

Conclusion

Our results suggest that AirSeal at 12 mmHg or more is a risk factor for symptomatic venous GE. Insufflation with lower pressure or alternative insufflation systems should be evaluated during LLR.

背景:腹腔镜肝切除术(LLR)中症状性静脉气体栓塞(GE)的危险因素尚不清楚。本研究的目的是报告LLR期间症状性GE的发生率、危险因素和发病率。方法:回顾性研究所有在法国3个中心连续3年接受LLR的患者。收集并回顾所有术中事件,重点是症状性静脉GE。结果:在518例LLR(507例)患者中,26例(5%)出现了症状性GE。GE后无GE相关死亡或神经系统后遗症。GE组和非GE组在基线特征、切除类型、气腹压力(93%的LLR≤12 mmHg)或术中出血方面相似。GE后的总体发病率和住院时间更长。在12 mmHg的Airseal充气系统下,GE的概率更高(Airseal为7.1%,常规系统为0.59%,优势比为12.73,95%可信区间[2.66-228.4],p = 0.013)。结论:我们的研究结果表明,12mmhg或更高的AirSeal是症状性静脉GE的危险因素。在LLR期间,应评估低压充气或替代充气系统。
{"title":"Incidence and Risk Factors of Symptomatic Venous Gas Embolism During Laparoscopic Liver Resection","authors":"Walid Hadji,&nbsp;Nassiba Beghdadi,&nbsp;Chady Salloum,&nbsp;Claire Goumard,&nbsp;Safi Dokmak,&nbsp;Chetana Lim,&nbsp;Stéphanie Roullet,&nbsp;Rania Bounab,&nbsp;Djillali Annane,&nbsp;Mickaël Lesurtel,&nbsp;Olivier Scatton,&nbsp;Daniel Cherqui,&nbsp;Marc Antoine Allard","doi":"10.1002/jhbp.70013","DOIUrl":"10.1002/jhbp.70013","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Risk factors of symptomatic venous gas embolism (GE) during laparoscopic liver resection (LLR) are poorly known. The objective of this study was to report the incidence, risk factors, and morbidity of symptomatic GE during LLR.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>All consecutive patients who underwent LLR in 3 French centers over 3 years were retrospectively studied. All intraoperative events, with a focus on symptomatic venous GE, were collected and reviewed.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among the 518 LLR (507 patients) studied, 26 (5%) cases of symptomatic GE occurred. There was no GE-related death nor neurological sequelae after GE. The group of patients with GE and without GE was similar in terms of baseline characteristics, type of resection, and pneumoperitoneum pressure (≤ 12 mmHg in 93% of LLR) or intraoperative bleeding. Overall morbidity and length of stay were longer after GE. The probability of GE was higher under the Airseal insufflation system at 12 mmHg (7.1% with Airseal versus 0.59% with conventional systems, odds ratio 12.73, 95% confidence interval [2.66–228.4], <i>p</i> = 0.013).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Our results suggest that AirSeal at 12 mmHg or more is a risk factor for symptomatic venous GE. Insufflation with lower pressure or alternative insufflation systems should be evaluated during LLR.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16056,"journal":{"name":"Journal of Hepato‐Biliary‐Pancreatic Sciences","volume":"32 12","pages":"865-870"},"PeriodicalIF":2.8,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145251510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characteristics and Outcomes of Declined Adult Liver Allografts due to Donor-Related Medical Reasons in Japan: Insights for Safe Utilization 日本因供体相关医学原因导致成人同种异体肝脏移植减少的特点和结果:安全使用的见解
IF 2.8 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-09-23 DOI: 10.1002/jhbp.70015
Junya Mita, Yusuke Takemura, Juntaro Ashikari, Kaori Kuramitsu, Shohei Yoshiya, Takeo Toshima, Shinji Itoh, Hiroto Egawa, Tomoharu Yoshizumi, Hiroyuki Yokota

Background

Few studies have evaluated allografts that were declined before the acceptance for deceased-donor liver transplantation. We aimed to elucidate the characteristics of these allografts and assess their transplantation outcomes.

Methods

We analyzed data from 730 adult liver allografts transplanted between July 2010 and March 2024. Clinical characteristics of the transplanted allografts were evaluated according to the number of declines, and the outcomes of the recipients were analyzed.

Results

Transplanted allografts were categorized into three groups: ≥ 5 declined (n = 41), 1–4 declined (n = 104), and no declined group (n = 585). The ≥ 5 declined group exhibited high liver enzyme levels and steatosis. Within this group, the Japan Risk Index and total ischemic time (TIT) were identified as poor prognostic factors. Notably, in cases where TIT exceeded 10 h, a poor prognosis was observed in the ≥ 5 declined group.

Conclusion

Abnormal liver functions or steatosis were observed in the ≥ 5 declined group. Shortening the TIT could contribute to an improved prognosis after transplantation.

背景:很少有研究评估同种异体移植物在接受死亡供体肝移植之前的表现。我们的目的是阐明这些同种异体移植物的特点,并评估其移植结果。方法:我们分析了2010年7月至2024年3月期间移植的730例成人同种异体肝脏移植的数据。根据下降次数评估同种异体移植物移植的临床特征,并分析受者的结果。结果:移植同种异体移植物分为3组:≥5个衰退组(n = 41), 1-4个衰退组(n = 104),无衰退组(n = 585)。≥5下降组表现为高肝酶水平和脂肪变性。在该组中,日本风险指数和总缺血时间(TIT)被确定为不良预后因素。值得注意的是,当TIT超过10 h时,≥5下降组的预后较差。结论:≥5衰组存在肝功能异常或脂肪变性。缩短TIT可以改善移植后的预后。
{"title":"Characteristics and Outcomes of Declined Adult Liver Allografts due to Donor-Related Medical Reasons in Japan: Insights for Safe Utilization","authors":"Junya Mita,&nbsp;Yusuke Takemura,&nbsp;Juntaro Ashikari,&nbsp;Kaori Kuramitsu,&nbsp;Shohei Yoshiya,&nbsp;Takeo Toshima,&nbsp;Shinji Itoh,&nbsp;Hiroto Egawa,&nbsp;Tomoharu Yoshizumi,&nbsp;Hiroyuki Yokota","doi":"10.1002/jhbp.70015","DOIUrl":"10.1002/jhbp.70015","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Few studies have evaluated allografts that were declined before the acceptance for deceased-donor liver transplantation. We aimed to elucidate the characteristics of these allografts and assess their transplantation outcomes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We analyzed data from 730 adult liver allografts transplanted between July 2010 and March 2024. Clinical characteristics of the transplanted allografts were evaluated according to the number of declines, and the outcomes of the recipients were analyzed.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Transplanted allografts were categorized into three groups: ≥ 5 declined (<i>n</i> = 41), 1–4 declined (<i>n</i> = 104), and no declined group (<i>n</i> = 585). The ≥ 5 declined group exhibited high liver enzyme levels and steatosis. Within this group, the Japan Risk Index and total ischemic time (TIT) were identified as poor prognostic factors. Notably, in cases where TIT exceeded 10 h, a poor prognosis was observed in the ≥ 5 declined group.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Abnormal liver functions or steatosis were observed in the ≥ 5 declined group. Shortening the TIT could contribute to an improved prognosis after transplantation.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16056,"journal":{"name":"Journal of Hepato‐Biliary‐Pancreatic Sciences","volume":"32 12","pages":"878-892"},"PeriodicalIF":2.8,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145131092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Factors and Strategies for Failure to Rescue Following Hepatectomy: A Review 肝切除术后抢救失败的危险因素和策略:综述。
IF 2.8 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-09-22 DOI: 10.1002/jhbp.70014
Jiro Kimura, Kosei Takagi, Tomokazu Fuji, Kazuya Yasui, Takeyoshi Nishiyama, Toshiyoshi Fujiwara

Failure to rescue (FTR), defined as mortality after major postoperative complications, is a crucial indicator of surgical quality. Although mortality rates after hepatectomy have declined owing to improved surgical techniques and perioperative care, FTR remains a major concern. This review synthesizes the current evidence on the risk factors contributing to FTR after hepatectomy and explores multidisciplinary strategies to reduce its rate. Post-hepatectomy liver failure, hemorrhage, bile leakage, and sepsis commonly precede FTR. Risk factors for FTR are multifactorial and include patient-, procedure-, and system-related factors. Higher procedural volumes are associated with lower FTR rates, likely due to better infrastructure, experienced personnel, and access to rapid interventions. Strategies to reduce the FTR rate include preoperative optimization, intraoperative precision, and vigilant postoperative surveillance. System-level approaches, such as multidisciplinary rounds, standardized escalation protocols, and a robust institutional safety culture, are also pivotal. Future innovations, such as predictive analytics, artificial intelligence, and wearable monitoring devices, offer considerable potential for the early detection of complications. Centralization of complex liver surgeries to high-volume centers is recommended to enhance team preparedness. This review emphasizes the importance of adopting a comprehensive, proactive, and technologically integrated approach to reduce the FTR rate after hepatectomy and improve patient survival.

抢救失败(FTR)定义为术后主要并发症后的死亡率,是衡量手术质量的重要指标。尽管由于手术技术和围手术期护理的改进,肝切除术后的死亡率有所下降,但肝术后复发率仍然是一个主要问题。本综述综合了目前肝切除术后发生FTR的危险因素的证据,并探讨了降低其发生率的多学科策略。肝切除术后肝衰竭、出血、胆漏和败血症通常发生在FTR之前。FTR的危险因素是多因素的,包括患者、手术和系统相关因素。较高的手术量与较低的FTR率相关,这可能是由于更好的基础设施、经验丰富的人员和获得快速干预措施的机会。降低FTR率的策略包括术前优化、术中精确和术后警惕监测。系统级方法,如多学科轮次、标准化升级协议和健全的机构安全文化,也至关重要。未来的创新,如预测分析、人工智能和可穿戴监控设备,为早期发现并发症提供了巨大的潜力。建议将复杂的肝脏手术集中到大容量的中心,以加强团队的准备。这篇综述强调了采用全面、主动和技术综合的方法来降低肝切除术后的FTR率和提高患者生存率的重要性。
{"title":"Risk Factors and Strategies for Failure to Rescue Following Hepatectomy: A Review","authors":"Jiro Kimura,&nbsp;Kosei Takagi,&nbsp;Tomokazu Fuji,&nbsp;Kazuya Yasui,&nbsp;Takeyoshi Nishiyama,&nbsp;Toshiyoshi Fujiwara","doi":"10.1002/jhbp.70014","DOIUrl":"10.1002/jhbp.70014","url":null,"abstract":"<p>Failure to rescue (FTR), defined as mortality after major postoperative complications, is a crucial indicator of surgical quality. Although mortality rates after hepatectomy have declined owing to improved surgical techniques and perioperative care, FTR remains a major concern. This review synthesizes the current evidence on the risk factors contributing to FTR after hepatectomy and explores multidisciplinary strategies to reduce its rate. Post-hepatectomy liver failure, hemorrhage, bile leakage, and sepsis commonly precede FTR. Risk factors for FTR are multifactorial and include patient-, procedure-, and system-related factors. Higher procedural volumes are associated with lower FTR rates, likely due to better infrastructure, experienced personnel, and access to rapid interventions. Strategies to reduce the FTR rate include preoperative optimization, intraoperative precision, and vigilant postoperative surveillance. System-level approaches, such as multidisciplinary rounds, standardized escalation protocols, and a robust institutional safety culture, are also pivotal. Future innovations, such as predictive analytics, artificial intelligence, and wearable monitoring devices, offer considerable potential for the early detection of complications. Centralization of complex liver surgeries to high-volume centers is recommended to enhance team preparedness. This review emphasizes the importance of adopting a comprehensive, proactive, and technologically integrated approach to reduce the FTR rate after hepatectomy and improve patient survival.</p>","PeriodicalId":16056,"journal":{"name":"Journal of Hepato‐Biliary‐Pancreatic Sciences","volume":"32 11","pages":"801-809"},"PeriodicalIF":2.8,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jhbp.70014","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145124882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Characteristics and Predictors of Acute Cholangitis With Enterococcal-Positive Bile Cultures: A Retrospective Study 肠球菌阳性胆汁培养急性胆管炎的临床特征和预测因素:一项回顾性研究。
IF 2.8 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-09-22 DOI: 10.1002/jhbp.70012
Junichi Kaneko, Masaki Takinami, Akihiro Anma, Daijiro Suzuki, Kohei Nishizawa, Yuichi Hirano, Tomoyuki Niwa, Atsushi Kato, Yurimi Takahashi, Masafumi Nishino

Background

Enterococci are commonly isolated from bile cultures in patients with acute cholangitis (AC) and pose a global concern owing to antibiotic resistance. This study identified predictive factors and clinical characteristics of AC with enterococcal-positive bile cultures.

Methods

Consecutive patients with AC and bactobilia who underwent endoscopic retrograde cholangiopancreatography between April 2022 and March 2024 were included. Patients were categorized into enterococcal (E) and non-E groups based on bile culture results. Predictive factors for enterococcal positivity were analyzed. Empirical antibiotic coverage and clinical outcomes (symptom duration, length of antibiotic therapy, in-hospital mortality, and short-term recurrence) were compared within all-grade and severe AC.

Results

Among 250 patients, 100 with enterococcal-positive bile cultures formed the E group. Predictive factors included age > 71 years, immunosuppressed status, prior endoscopic sphincterotomy, and prior biliary stenting. Inappropriate empirical antibiotic coverage was more frequent in the E group across both severity categories. Clinical outcomes did not differ among all-grade patients except for higher short-term recurrence in the E group. No significant differences were observed among severe patients for any clinical outcome.

Conclusions

Enterococcal-positive bile cultures are predicted by specific factors. Despite frequent inadequate empirical antibiotic coverage, most clinical outcomes were similar to those for non-enterococcal patients.

背景:肠球菌通常从急性胆管炎(AC)患者的胆汁培养物中分离出来,由于抗生素耐药性而引起全球关注。本研究确定肠球菌胆汁培养阳性AC的预测因素和临床特征。方法:纳入2022年4月至2024年3月期间连续行内窥镜逆行胆管造影的AC和胆管杆菌症患者。根据胆汁培养结果将患者分为肠球菌(E)组和非E组。分析肠球菌阳性的预测因素。比较了所有级别和严重ac的经验抗生素覆盖率和临床结果(症状持续时间、抗生素治疗时间、住院死亡率和短期复发率)。结果:250例患者中,100例肠球菌胆汁培养阳性组成E组。预测因素包括年龄100 ~ 71岁、免疫抑制状态、既往内镜下括约肌切开术和既往胆道支架置入术。在E组中,不适当的经验性抗生素覆盖在两种严重程度类别中更为常见。除了E级患者的短期复发率较高外,所有级别患者的临床结果没有差异。重症患者的任何临床结果均无显著差异。结论:肠球菌阳性胆汁培养可由特定因素预测。尽管经验性抗生素覆盖率经常不足,但大多数临床结果与非肠球菌患者相似。
{"title":"Clinical Characteristics and Predictors of Acute Cholangitis With Enterococcal-Positive Bile Cultures: A Retrospective Study","authors":"Junichi Kaneko,&nbsp;Masaki Takinami,&nbsp;Akihiro Anma,&nbsp;Daijiro Suzuki,&nbsp;Kohei Nishizawa,&nbsp;Yuichi Hirano,&nbsp;Tomoyuki Niwa,&nbsp;Atsushi Kato,&nbsp;Yurimi Takahashi,&nbsp;Masafumi Nishino","doi":"10.1002/jhbp.70012","DOIUrl":"10.1002/jhbp.70012","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Enterococci are commonly isolated from bile cultures in patients with acute cholangitis (AC) and pose a global concern owing to antibiotic resistance. This study identified predictive factors and clinical characteristics of AC with enterococcal-positive bile cultures.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Consecutive patients with AC and bactobilia who underwent endoscopic retrograde cholangiopancreatography between April 2022 and March 2024 were included. Patients were categorized into enterococcal (E) and non-E groups based on bile culture results. Predictive factors for enterococcal positivity were analyzed. Empirical antibiotic coverage and clinical outcomes (symptom duration, length of antibiotic therapy, in-hospital mortality, and short-term recurrence) were compared within all-grade and severe AC.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among 250 patients, 100 with enterococcal-positive bile cultures formed the E group. Predictive factors included age &gt; 71 years, immunosuppressed status, prior endoscopic sphincterotomy, and prior biliary stenting. Inappropriate empirical antibiotic coverage was more frequent in the E group across both severity categories. Clinical outcomes did not differ among all-grade patients except for higher short-term recurrence in the E group. No significant differences were observed among severe patients for any clinical outcome.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Enterococcal-positive bile cultures are predicted by specific factors. Despite frequent inadequate empirical antibiotic coverage, most clinical outcomes were similar to those for non-enterococcal patients.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16056,"journal":{"name":"Journal of Hepato‐Biliary‐Pancreatic Sciences","volume":"32 12","pages":"893-900"},"PeriodicalIF":2.8,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145124892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Shifting Target: Redefining Timing and Risk in the Management of Mucinous Pancreatic Cysts 转移目标:重新定义胰腺粘液囊肿治疗的时机和风险。
IF 2.8 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-09-18 DOI: 10.1002/jhbp.70001
Riccardo Pellegrini, Hiroyuki Ishida, Richard D. Schulick, Marco Del Chiaro
{"title":"The Shifting Target: Redefining Timing and Risk in the Management of Mucinous Pancreatic Cysts","authors":"Riccardo Pellegrini,&nbsp;Hiroyuki Ishida,&nbsp;Richard D. Schulick,&nbsp;Marco Del Chiaro","doi":"10.1002/jhbp.70001","DOIUrl":"10.1002/jhbp.70001","url":null,"abstract":"","PeriodicalId":16056,"journal":{"name":"Journal of Hepato‐Biliary‐Pancreatic Sciences","volume":"33 1","pages":"6-7"},"PeriodicalIF":2.8,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jhbp.70001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145080769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Natural History and Risk Factors of Splenic Infarction After Spleen-Preserving Distal Pancreatectomy Using the Warshaw Technique Warshaw技术保脾远端胰腺切除术后脾梗死的自然历史及危险因素。
IF 2.8 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-09-17 DOI: 10.1002/jhbp.70009
Eyad Ebrahim, Hochang Chae, Hyeong Seok Kim, So Jeong Yoon, Sang Hyun Shin, In Woong Han, Jin Seok Heo, Hongbeom Kim

Background

The Warshaw technique for spleen-preserving distal pancreatectomy (SPDP), which sacrifices splenic vessels, is widely used for benign and borderline malignant pancreatic diseases due to its technical simplicity. However, it carries the risk of splenic infarction.

This study aimed to evaluate the incidence, risk factors, and clinical course of splenic infarction in patients who underwent SPDP using the Warshaw technique.

Methods

Patients who underwent SPDP using the Warshaw technique at the Samsung Medical Center between 2007 and 2022 were retrospectively analyzed. Postoperative computed tomography scans were reviewed by a single researcher to classify splenic infarction severity based on the extent of infarction.

Results

About 158 patients underwent the Warshaw technique. Splenic infarction was observed in 75 patients (47.5%). Among these, 34 cases (21.5%) were classified as severe (> 50%) infarction.

Univariate and multivariate analysis identified previous abdominal surgery as the only statistically significant risk factor. Among the 75 patients with splenic infarction, two required antibiotic management, while none required radiological intervention.

Conclusion

Splenic infarction after SPDP using the Warshaw technique was clinically insignificant. These findings support the use of the Warshaw technique as a feasible and effective option for treating benign and borderline malignant pancreatic diseases.

背景:Warshaw保脾远端胰腺切除术(SPDP)由于技术简单,被广泛应用于良性和交界性恶性胰腺疾病。然而,它有脾梗死的风险。本研究旨在评估使用Warshaw技术行SPDP患者脾梗死的发生率、危险因素和临床病程。方法:回顾性分析2007年至2022年在三星医疗中心采用Warshaw技术行SPDP的患者。术后计算机断层扫描由一名研究人员根据梗死的程度对脾梗死的严重程度进行分类。结果:158例患者行Warshaw手术。脾梗死75例(47.5%)。其中34例(21.5%)为重度梗死(50%)。单因素和多因素分析确定既往腹部手术是唯一具有统计学意义的危险因素。75例脾梗死患者中,2例需要抗生素治疗,无一例需要放射治疗。结论:Warshaw技术在SPDP术后发生脾梗死无临床意义。这些发现支持使用Warshaw技术作为治疗良性和交界性恶性胰腺疾病的可行和有效的选择。
{"title":"Natural History and Risk Factors of Splenic Infarction After Spleen-Preserving Distal Pancreatectomy Using the Warshaw Technique","authors":"Eyad Ebrahim,&nbsp;Hochang Chae,&nbsp;Hyeong Seok Kim,&nbsp;So Jeong Yoon,&nbsp;Sang Hyun Shin,&nbsp;In Woong Han,&nbsp;Jin Seok Heo,&nbsp;Hongbeom Kim","doi":"10.1002/jhbp.70009","DOIUrl":"10.1002/jhbp.70009","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>The Warshaw technique for spleen-preserving distal pancreatectomy (SPDP), which sacrifices splenic vessels, is widely used for benign and borderline malignant pancreatic diseases due to its technical simplicity. However, it carries the risk of splenic infarction.</p>\u0000 \u0000 <p>This study aimed to evaluate the incidence, risk factors, and clinical course of splenic infarction in patients who underwent SPDP using the Warshaw technique.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Patients who underwent SPDP using the Warshaw technique at the Samsung Medical Center between 2007 and 2022 were retrospectively analyzed. Postoperative computed tomography scans were reviewed by a single researcher to classify splenic infarction severity based on the extent of infarction.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>About 158 patients underwent the Warshaw technique. Splenic infarction was observed in 75 patients (47.5%). Among these, 34 cases (21.5%) were classified as severe (&gt; 50%) infarction.</p>\u0000 \u0000 <p>Univariate and multivariate analysis identified previous abdominal surgery as the only statistically significant risk factor. Among the 75 patients with splenic infarction, two required antibiotic management, while none required radiological intervention.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Splenic infarction after SPDP using the Warshaw technique was clinically insignificant. These findings support the use of the Warshaw technique as a feasible and effective option for treating benign and borderline malignant pancreatic diseases.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16056,"journal":{"name":"Journal of Hepato‐Biliary‐Pancreatic Sciences","volume":"32 12","pages":"920-927"},"PeriodicalIF":2.8,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145075398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to “Novel Method to Prevent Severe Postoperative Pancreatic Fistula Caused by Lipolysis” 对“预防脂肪溶解所致严重术后胰瘘的新方法”的更正。
IF 2.8 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-09-17 DOI: 10.1002/jhbp.70010

Nakamura N, Nagai K, Kaneda A, Yogo A, Kasai Y, Anazawa T, Uchida Y, Masui T, Tabata Y, Hatano E.J Hepatobiliary Pancreat Sci. 2025 Jun;32(6):476–486. https://doi.org/10.1002/jhbp.12128.

(1) On page 478, in Section 2.1 “Experimental study,” the text “body weight, and doses of 0.1, 10, and 50 mg/body were” was incorrect. The correct version should be: “body weight, and doses of 0, 1, 10, and 50 mg/body were.”

(2) On page 482, in the survival curve of “FIGURE 4 m. Survival,” the label “PT+F+【C10mg+P80/G7】” was incorrect.

It should be corrected to: “PT+F+【C10mg+P80/PEG-HG】.”

No corrections are needed in the figure legend.

We apologize for these errors.

中村一,金田一,金田一,金田一,金田一,金田一,金田一,金田一,金田一,金田一,田田一,田田一,田田一,田田一,田田一,田田一,田田一,田野一等。https://doi.org/10.1002/jhbp.12128.(1)在第478页的2.1节“实验研究”中,文本“体重,0.1,10和50毫克/人的剂量”是不正确的。正确的版本应该是:“体重和剂量分别为0、1、10和50毫克/人。”(2)第482页,在“图4 m。“PT+F+【C10mg+P80/G7】”标签不正确。应该更正为:“PT+F+【C10mg+P80/PEG-HG】”。图例中不需要修改。我们为这些错误道歉。
{"title":"Correction to “Novel Method to Prevent Severe Postoperative Pancreatic Fistula Caused by Lipolysis”","authors":"","doi":"10.1002/jhbp.70010","DOIUrl":"10.1002/jhbp.70010","url":null,"abstract":"<p>Nakamura N, Nagai K, Kaneda A, Yogo A, Kasai Y, Anazawa T, Uchida Y, Masui T, Tabata Y, Hatano E.J Hepatobiliary Pancreat Sci. 2025 Jun;32(6):476–486. https://doi.org/10.1002/jhbp.12128.</p><p>(1) On page 478, in Section 2.1 “Experimental study,” the text “body weight, and doses of 0.1, 10, and 50 mg/body were” was incorrect. The correct version should be: “body weight, and doses of 0, 1, 10, and 50 mg/body were.”</p><p>(2) On page 482, in the survival curve of “FIGURE 4 m. Survival,” the label “PT+F+【C10mg+P80/G7】” was incorrect.</p><p>It should be corrected to: “PT+F+【C10mg+P80/PEG-HG】.”</p><p>No corrections are needed in the figure legend.</p><p>We apologize for these errors.</p>","PeriodicalId":16056,"journal":{"name":"Journal of Hepato‐Biliary‐Pancreatic Sciences","volume":"32 11","pages":"863-864"},"PeriodicalIF":2.8,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jhbp.70010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145075473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Hepato‐Biliary‐Pancreatic Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1